All news (page 43)

• 

  31 March 2026

  Chevron in exclusivity talks with Microsoft and Engine No. 1 on power offtake

  AI is increasing demand for always-on power. Parties entered exclusivity talks for a co-located, behind-the-meter power generation and offtake deal; no commercial terms or definitive agreement yet.
• 

  31 March 2026

  Mesabi Metallics secures $520M Breakwall financing to advance U.S. DR iron-ore project

  Northern Minnesota DR-grade iron ore mine and pellet plant on 16,000+ acres progressing toward commercial start; $2.5B project, 750+ construction workers onsite, backed by EXIM support.
• 

  31 March 2026

  BASF launches Butyl and 2‑Ethylhexyl Acrylate RE with Avery Dennison

  Launches butyl and 2‑ethylhexyl acrylates made using attributed Texas renewable electricity; drop‑in for coatings and adhesives, reducing manufacturing CO2; commercialization supported by partner.
• 

  31 March 2026

  Symrise launches Cellexora MD: plant‑derived exosomes for skin regeneration

  Upcycled Italian apple side-stream extract: 100% natural, stable, water-soluble powder that boosts collagen, soothes skin and reduces wrinkles in 30 days; sustainable and formulation-friendly.
• 

  31 March 2026

  Kemira completes first US full-scale trial of chlorine-free KemConnect DEX

  Trial with Capital Region Water shows a performic-acid, chlorine-free treatment cut bacteria rapidly at low doses, auto-degraded to biodegradable compounds and auto-adjusted dosing.
• 

  31 March 2026

  LanzaTech Q4 & FY2025 Financial Results

  Closed $20M private placement; awarded €40M EU grant; completed LanzaJet share transfers (peak 53%, later ~46% after Series A); revenue $55.8M; net loss $49M; opex -21%

• 

  31 March 2026

  OMV and XRG form Borouge International

  Merger of Borouge, Borealis and NOVA creates global pure‑play polyolefins leader with 13.6 Mtpa capacity, >$500M synergies, advantaged feedstock and investment‑grade ratings
• 

  31 March 2026

  Topsoe elects employee representatives to Board

  Employee reps elected for four years: Line Holten Kollin, Lis Ibsen (re-elected); Adam Samir Kadhim and Ignacio Fabian Costa (new). Seats effective after AGM 16 Apr 2026
• 

  31 March 2026

  OCI Global sells OCI Ammonia Holding to AGROFERT

  100% stake in ammonia holding sold for EUR 290m (subject to closing adjustments). Sale includes Europoort terminal and distribution; Geleen production retains terminal access via throughput agreement.
• 

  31 March 2026

  PPG showcases electrocoat and digital innovations at ECOAT 26

  At ECOAT 26, new pretreatment and electrocoat technologies, digital paint‑shop tools and services to cut waste and costs, boost efficiency; exec keynote and interactive demo included.
• 

  31 March 2026

  Covestro at Techtextil 2026: sustainable, productivity-focused textile solutions

  Showcases coatings, adhesive films and TPUs: waterborne/partly bio-based PUs, antimicrobial finishes, high-performance TPU films for electronics/CIPP, recyclable cushioning and SCF-foamable TPUs
• 

  31 March 2026

  Johnson Matthey DPFi DPF earns Canadian CSA certification

  Electrically regenerating diesel particulate filter certified by CSA for Canadian underground mining/tunnelling; also certified by Canmet and VERT and approved by US MSHA.
• 

  31 March 2026

  BASF launches biomass‑balanced Ultrason® P 3010 BMB PPSU

  New Ultrason P 3010 BMB is ISCC‑PLUS certified, 20% biomass‑balanced PPSU (mass‑balance), matches standard grade in properties and certifications, drop‑in replacement made with green electricity.
• 

  31 March 2026

  Gestamp signs 10-year renewable PPA with Iberdrola for 660,000 MWh

  Supply of 100% renewable power (80% wind/20% solar) from 34 MW capacity at fixed competitive price; supports electrification and decarbonisation of the auto supply chain. Certificates of origin.
• 

  31 March 2026

  Lilly to acquire Centessa Pharmaceuticals for OX2R sleep‑wake portfolio

  $38/ADS cash + up to $9 CVR (max $47/sh); upfront equity ~$6.3B (CVR ~$1.5B). Lead OX2R agonist cleminorexton showed positive Phase 2a for narcolepsy and idiopathic hypersomnia. Close expected Q3
• 

  31 March 2026

  Umicore opens Shanghai innovation center

  New 3,600 sqm Shanghai innovation center, first corporate R&D outside Europe; focuses on fuel cells and recycling, expanding to catalysis for renewables, CO2 capture, H2, and local partnerships.
• 

  31 March 2026

  Messer 2025 results: €4.5bn revenue, €1.4bn EBITDA, €747m investments

  Stable 2025: margin held, net debt reduced, staff >12k. Investments in air-separation, on-site/CO2/cylinder plants, helium, decarbonization, R&D/digitalization. 2026 growth expected.
• 

  31 March 2026

  Mitsubishi Gas Chemical to End Polycarbonate Production at Kashima Plant

  Discontinuing Kashima polycarbonate plant in March 2028 (120k t/yr) due to weak margins and oversupply. Domestic supply to shift to overseas sites; employees prioritized; financial impact under review.
• 

  31 March 2026

  Topsoe signs FEED deal with Hynfra for Jordan green ammonia

  FEED underway for Jordan green ammonia: synthesis tech will convert green H2 to ammonia, avoiding >200,000 t CO2e/yr. FID expected 2027; plant to start 2030; exports planned.
• 

  31 March 2026

  Mitsubishi Chemical transfers KMC MMA monomer stake in Taiwan to CPDC

  Dissolve co-ownership of Taiwan MMA unit amid stronger Asian competition and Chinese capacity growth; consolidate production to competitive sites and pursue high-growth markets. Completion Aug 3, 2026.
• 

  31 March 2026

  Sumisho Venture Partners launches ¥10 billion fund

  Shifting to a fund structure to enable medium/long‑term, larger lead investments, deepen portfolio engagement and co‑creation, and pursue strategic and financial returns in digital, AI and deep tech
• 

  30 March 2026

  Holcim acquires majority stake in Cementos Pacasmayo

  Acquisition expands Peru footprint: target had 2025 sales $630M, 28% adj. EBITDA; 3 plants (~5Mtpa) and 28 ready-mix/precast sites. Deal ~7.1x EBITDA post $40M synergies; EPS accretive Y1, ROIC Y3.
• 

  30 March 2026

  Golden Pass LNG (QatarEnergy/ExxonMobil) achieves first LNG production

  First LNG produced from Train 1 of the 18 mtpa Sabine Pass project, enabling sustained liquefaction and paving way for first cargo and full exports beginning Q2 2026.
• 

  30 March 2026

  PETRONAS Monitors Malaysia’s Fuel Supply

  Fuel supply strained by West Asia crisis—~40% of crude via Strait of Hormuz; crude prices +40%, shipping and insurance up. Domestic demand exceeds supply; govt subsidises RON95/diesel; avoid hoarding.
• 

  30 March 2026

  Dow’s Carbon Footprint Ledger wins 2026 CIO 100 Award

  Recognized for enabling verifiable PCF certificates, optimizing low‑GHG production pathways, and integrating supply‑chain, sustainability and finance data to scale trusted low‑carbon product offerings.
• 

  30 March 2026

  Merck enlicitide decanoate, an oral PCSK9 inhibitor, reduces LDL‑C more than guideline non‑statins at 8 weeks

  Phase 3 CORALreef AddOn: enlicitide lowered LDL‑C 64.6% at 8 weeks; 78.2% achieved ≥50% reduction and LDL‑C <55 mg/dL; safety comparable to oral non‑statins; FDA CNPV awarded
• 

  30 March 2026

  Siemens USA appoints Ann Fairchild President & CEO

  Ann Fairchild, with 25+ years at the company, named permanent president & CEO of its U.S. unit; will oversee ~50,000 employees and $24B revenue, focusing on AI, infrastructure and reshoring.
• 

  30 March 2026

  LKAB raises mineral resources by 900 million tonnes to 7.2 billion tonnes

  Exploration added volume and confidence; reserves ~0.9 Gt. Resources grew mainly at Malmberget; Per Geijer hosts 2.2 Mt REO in situ and phosphorus. EU strategic status granted.
• 

  30 March 2026

  Velocys and SuMo commission Fischer–Tropsch unit at Wednesbury for UK waste-to-SAF

  FT unit at Wednesbury is online and stable, validating integration of gasification and FT for waste-to-SAF and supporting ClearSkies demonstration toward modular, scalable SAF production.
• 

  30 March 2026

  BASF Pharma Solutions raises prices up to 20% for excipients and selected APIs

  Price change for excipients and selected APIs to support reliable supply amid rising energy and raw-material costs. Effective immediately or per contracts; company will monitor and update.